Follicular Lymphoma


FDA Approves Aliqopa for Treatment of Adults with Relapsed Follicular Lymphoma (10-18-2017)

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies. “For patients... Continue Reading